Penumbra Inc (STU:0P8)
€ 166.25 -0.75 (-0.45%) Market Cap: 6.53 Bil Enterprise Value: 6.43 Bil PE Ratio: 551.91 PB Ratio: 6.28 GF Score: 86/100

Penumbra Inc at BMO Capital Markets Prescription for Success Healthcare Conference Transcript

Jun 25, 2019 / 02:00PM GMT
Release Date Price: €147.14 (+1.41%)
Joanne Karen Wuensch
BMO Capital Markets Equity Research - MD & Research Analyst

All right. Well, we're going to move on to our next presentation. Just looking for my mic, which is somewhere. Hi, everybody. The next presentation today is from Penumbra, and I'm thrilled to have Sri here, their CFO. Thank you so much for joining us on this rainy day in New York.

Sridhar N. Kosaraju
Penumbra, Inc. - CFO & Head of Strategy

Thank you for having us. Thank you.

Questions & Answers

Joanne Karen Wuensch
BMO Capital Markets Equity Research - MD & Research Analyst

Let's get started, just sort of big picture, and then dig down from there. We've been talking over time about sort of the 2 regions or the 2 franchises for Penumbra: neurovascular and peripheral vascular. And then more recently, we're moving into other spaces, cardiovascular, and then there's always something else that seems out there. So let's talk about how the company thinks about making investments in these areas with any investments in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot